Araclon Biotech partners with TFS International to advance AD vaccine ABvac40 into Phase II Read more
Liquidia proclaimed positive Phase1 and Preclinical results for LIQ861 for treatment of PAH Read more
COMPASS Trial results advocate Penumbra’s Frontline Thrombectomy approach for Acute Ischemic Stroke Read more